Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 263

1.

Influence of cellular ERalpha/ERbeta ratio on the ERalpha-agonist induced proliferation of human T47D breast cancer cells.

Sotoca AM, van den Berg H, Vervoort J, van der Saag P, Ström A, Gustafsson JA, Rietjens I, Murk AJ.

Toxicol Sci. 2008 Oct;105(2):303-11. doi: 10.1093/toxsci/kfn141. Epub 2008 Jul 21.

2.

Cell proliferation and modulation of interaction of estrogen receptors with coregulators induced by ERα and ERβ agonists.

Evers NM, van den Berg JH, Wang S, Melchers D, Houtman R, de Haan LH, Ederveen AG, Groten JP, Rietjens IM.

J Steroid Biochem Mol Biol. 2014 Sep;143:376-85. doi: 10.1016/j.jsbmb.2014.06.002. Epub 2014 Jun 9.

PMID:
24923734
3.
4.

Estrogen and the selective estrogen receptor modulator (SERM) protection against cell death in estrogen receptor alpha and beta expressing U2OS cells.

Kallio A, Guo T, Lamminen E, Seppänen J, Kangas L, Väänänen HK, Härkönen P.

Mol Cell Endocrinol. 2008 Jul 16;289(1-2):38-48. doi: 10.1016/j.mce.2008.03.005. Epub 2008 Mar 25.

PMID:
18455292
5.

Functional characterization of estrogen receptor subtypes, ERalpha and ERbeta, mediating vitellogenin production in the liver of rainbow trout.

Leaños-Castañeda O, Van Der Kraak G.

Toxicol Appl Pharmacol. 2007 Oct 15;224(2):116-25. Epub 2007 Jul 4.

PMID:
17662327
6.

Selective oestrogen receptor modulators differentially potentiate brain mitochondrial function.

Irwin RW, Yao J, To J, Hamilton RT, Cadenas E, Brinton RD.

J Neuroendocrinol. 2012 Jan;24(1):236-48. doi: 10.1111/j.1365-2826.2011.02251.x.

7.

Inhibition of neointima formation by local delivery of estrogen receptor alpha and beta specific agonists.

Krom YD, Pires NM, Jukema JW, de Vries MR, Frants RR, Havekes LM, van Dijk KW, Quax PH.

Cardiovasc Res. 2007 Jan 1;73(1):217-26. Epub 2006 Nov 10.

PMID:
17141206
8.

Inhibition of mammary tumor growth by estrogens: is there a specific role for estrogen receptors alpha and beta?

Soldati R, Wargon V, Cerliani JP, Giulianelli S, Vanzulli SI, Gorostiaga MA, Bolado J, do Campo P, Molinolo A, Vollmer G, Lanari C.

Breast Cancer Res Treat. 2010 Oct;123(3):709-24. doi: 10.1007/s10549-009-0659-8. Epub 2009 Dec 11.

PMID:
20012353
9.

Transcriptional activity and biological effects of mammalian estrogen receptor ligands on three hepatic estrogen receptors in Mozambique tilapia.

Davis LK, Katsu Y, Iguchi T, Lerner DT, Hirano T, Grau EG.

J Steroid Biochem Mol Biol. 2010 Oct;122(4):272-8. doi: 10.1016/j.jsbmb.2010.05.009. Epub 2010 May 27.

PMID:
20553864
10.

Human T47D-ERβ breast cancer cells with tetracycline-dependent ERβ expression reflect ERα/ERβ ratios in rat and human breast tissue.

Evers NM, van de Klundert TM, van Aesch YM, Wang S, de Roos WK, Romano A, de Haan LH, Murk AJ, Ederveen AG, Rietjens IM, Groten JP.

Toxicol In Vitro. 2013 Sep;27(6):1753-61. doi: 10.1016/j.tiv.2013.04.014. Epub 2013 May 13.

PMID:
23680332
11.

Contribution of estrogen receptor subtypes, ERα, ERβ, and GPER1 in rapid estradiol-mediated enhancement of hippocampal synaptic transmission in mice.

Kumar A, Bean LA, Rani A, Jackson T, Foster TC.

Hippocampus. 2015 Dec;25(12):1556-66. doi: 10.1002/hipo.22475. Epub 2015 Jun 12.

12.

Phytoestrogen-mediated inhibition of proliferation of the human T47D breast cancer cells depends on the ERalpha/ERbeta ratio.

Sotoca AM, Ratman D, van der Saag P, Ström A, Gustafsson JA, Vervoort J, Rietjens IM, Murk AJ.

J Steroid Biochem Mol Biol. 2008 Dec;112(4-5):171-8. doi: 10.1016/j.jsbmb.2008.10.002. Epub 2008 Oct 8.

PMID:
18955141
13.

Indole-3-carbinol selectively uncouples expression and activity of estrogen receptor subtypes in human breast cancer cells.

Sundar SN, Kerekatte V, Equinozio CN, Doan VB, Bjeldanes LF, Firestone GL.

Mol Endocrinol. 2006 Dec;20(12):3070-82. Epub 2006 Aug 10.

PMID:
16901971
14.

Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.

Chen B, Gajdos C, Dardes R, Kidwai N, Johnston SR, Dowsett M, Jordan VC.

Int J Oncol. 2005 Aug;27(2):327-35.

PMID:
16010412
15.

Role of estrogen receptor-alpha and -beta in regulating leptin expression in 3T3-L1 adipocytes.

Yi KW, Shin JH, Seo HS, Lee JK, Oh MJ, Kim T, Saw HS, Kim SH, Hur JY.

Obesity (Silver Spring). 2008 Nov;16(11):2393-9. doi: 10.1038/oby.2008.389. Epub 2008 Aug 21.

16.

Roles of estrogen receptor alpha and beta in modulating urothelial cell proliferation.

Teng J, Wang ZY, Jarrard DF, Bjorling DE.

Endocr Relat Cancer. 2008 Mar;15(1):351-64. doi: 10.1677/erc.1.01255.

17.

Estrogen modulates in vitro T cell responses in a concentration- and receptor-dependent manner: effects on intracellular molecular targets and antioxidant enzymes.

Priyanka HP, Krishnan HC, Singh RV, Hima L, Thyagarajan S.

Mol Immunol. 2013 Dec;56(4):328-39. doi: 10.1016/j.molimm.2013.05.226. Epub 2013 Aug 1.

PMID:
23911387
18.

Both estrogen receptor alpha and estrogen receptor beta agonists enhance cell proliferation in the dentate gyrus of adult female rats.

Mazzucco CA, Lieblich SE, Bingham BI, Williamson MA, Viau V, Galea LA.

Neuroscience. 2006 Sep 15;141(4):1793-800. Epub 2006 Jun 23.

PMID:
16797852
19.

Sex specific response of cultured human bone cells to ERα and ERβ specific agonists by modulation of cell proliferation and creatine kinase specific activity.

Somjen D, Katzburg S, Sharon O, Knoll E, Hendel D, Stern N.

J Steroid Biochem Mol Biol. 2011 Jul;125(3-5):226-30. doi: 10.1016/j.jsbmb.2011.03.006. Epub 2011 Mar 21.

PMID:
21397017
20.

Contribution of estrogen receptors alpha and beta in the brain response to traumatic brain injury.

Asl SZ, Khaksari M, Khachki AS, Shahrokhi N, Nourizade S.

J Neurosurg. 2013 Aug;119(2):353-61. doi: 10.3171/2013.4.JNS121636. Epub 2013 May 31.

PMID:
23724987

Supplemental Content

Support Center